Berotralstat is a selective plasma kallikrein inhibitor utilized for the routine prophylaxis of hereditary angioedema attacks. This class of medication works by binding to plasma kallikrein to control… Read more
Berotralstat is a selective plasma kallikrein inhibitor utilized for the routine prophylaxis of hereditary angioedema attacks. This class of medication works by binding to plasma kallikrein to control its proteolytic activity, effectively reducing the generation of bradykinin that leads to swelling. To support the rigorous analytical demands of pharmaceutical quality control and research, this category provides essential reference standards, including the active pharmaceutical ingredient, its known impurities, and specific metabolites. Analytical laboratories rely on these high-quality compounds for precise impurity profiling and the validation of analytical methods to ensure product safety and consistency. Furthermore, the inclusion of stable isotope labelled compounds facilitates accurate quantification and the development of robust assays, particularly in complex bioanalytical studies. These materials serve as critical tools for chemists and researchers tasked with monitoring drug synthesis, stability, and regulatory compliance throughout the lifecycle of the compound.